Research Nurse 2 - Pediatric Oncology (Hybrid) Stanford UniversityResearch Nurse 2 - Pediatric Oncology (Hybrid)Stanford, CAReporting to the Pediatric Hematology/Oncology Clinical Research Nurse Manager, the Research Nurse 2 will be conversant in the goals, mission and priorities of the Institute, and utilize this knowledge to safely enroll and maintain follow-up for children and adults in Pediatric Oncology studies. PHYSICAL REQUIREMENTS*: Frequently stand/walk, sit, perform desk-based computer tasks, use a telephone, writing by hand, sort/file paperwork or parts, twist/bend/stoop/squat, and grasp lightly/fine manipulation.
Senior Clinical Scientist Abbott LaboratoriesSenior Clinical ScientistSanta Clara, CA$100,000–$200,000 / yearLearn more about our health and wellness benefits, which provide the security to help you and your family live full lives: www.abbottbenefits.com Follow your career aspirations to Abbott for diverse opportunities with a company that can help you build your future and live your best life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.
Senior Clinical Program Manager Revolution Medicines IncSenior Clinical Program ManagerRedwood City, CA$164,000–$205,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Ability to analyze operational data, contribute with a mind on quality, timeliness and fiscal responsibility, make and drive decisions, multi-task, prioritize tasks, anticipate challenges, and execute on goals as a member of an interdisciplinary team.
Clinical Trial Manager, CKD Maze TherapeuticsClinical Trial Manager, CKDSouth San Francisco, CA$143,000–$175,000 / yearThe company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
Senior Clinical Program Manager Revolution MedicinesSenior Clinical Program ManagerRedwood City, California$164,000–$205,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Ability to analyze operational data, contribute with a mind on quality, timeliness and fiscal responsibility, make and drive decisions, multi-task, prioritize tasks, anticipate challenges, and execute on goals as a member of an interdisciplinary team.
Senior Director, Clinical Data Management Revolution MedicinesSenior Director, Clinical Data ManagementRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials.
Senior Director, Clinical Data Management Revolution Medicines IncSenior Director, Clinical Data ManagementRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials.
Preclinical Discovery Research Associate Neurona Therapeutics IncPreclinical Discovery Research AssociateSouth San Francisco, CAWe are seeking a Preclinical Research Associate who will contribute to ongoing programs and help build new animal models to study modulation of neural circuits and support the translational development of cellular therapeutics. If you believe you have been a victim of a phishing scam, please visit the Cybersecurity & Infrastructure Security Agency (CISA) at: https://www.cisa.gov/be-cyber-smart/report-incident to learn how to report it.
Life Science Research Professional 2 Stanford UniversityLife Science Research Professional 2Stanford, CAThe Division of Gastroenterology and Hepatology has a long tradition of major contributions in basic research, a new commitment to clinical and outcomes research, a track record of training fellows for academic careers, and a longitudinal commitment to providing care for patients with complex gastrointestinal and liver diseases. They will need to participate in multidisciplinary, multi-center teams, be responsible for writing several key sections for NIH progress reports and renewal grant applications, help manage lab inventory and supplies, and supervise other staff and students as needed.
Director, Molecular Pathology, Translational Sciences, Translational Research. Revolution Medicines IncDirector, Molecular Pathology, Translational Sciences, Translational Research.Redwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: As a Director, Molecular Pathology, you will be a key member of a cross-functional Translational Sciences Team, reporting to the Senior Director and Head of Translational Sciences within Translational Research and will: Biomarker Strategy: Define and execute molecular and digital pathology-driven biomarker strategies.
Clinical Research Associate Neuralink CorpClinical Research AssociateFremont, CA$89,000–$148,000 / yearFrom navigating regulatory pathways, designing trial protocols and documentation, and executing clinical trials, our team is instrumental in translating Neuralink's BCI technology for use in people! Your work will directly contribute to the planning, execution, and success of innovative trials, from the initial phases of study setup to hands-on clinical monitoring and site management.
Director, Molecular Pathology, Translational Sciences, Translational Research. Revolution MedicinesDirector, Molecular Pathology, Translational Sciences, Translational Research.Redwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a Director, Molecular Pathology, you will be a key member of a cross-functional Translational Sciences Team, reporting to the Senior Director and Head of Translational Sciences within Translational Research and will: Biomarker Strategy: Define and execute molecular and digital pathology-driven biomarker strategies.
Executive Medical Director Immunology Clinical Development - RespiratoryPulmonary AbbVie IncExecutive Medical Director Immunology Clinical Development - RespiratoryPulmonarySouth San Francisco, CAActs as clinical lead and actively solicits opinion leader interactions related to the disease area(s); partners with Medical Affairs, Commercial and other functions in these activities as required, consistent with corporate policies, to ensure that broad cross-functional perspectives are incorporated into Clinical Development Plans and protocols as appropriate. Leads and demonstrates ownership of the design and implementation of multiple clinical development programs (or one large, complex program) in support of the overall product development plan, based on strong medical and scientific principles, knowledge of compliance and regulatory requirements, AbbVie's customers, markets, business operations, and emerging issues.
Senior Scientific Director Oncology Clinical Development Non-Hodgkin Lymphoma AbbVie IncSenior Scientific Director Oncology Clinical Development Non-Hodgkin LymphomaSouth San Francisco, CAActs as clinical lead and actively solicits opinion leader interactions related to the disease area(s); partners with Medical Affairs, Commercial and other functions in these activities as required, consistent with corporate policies, to ensure that broad cross-functional perspectives are incorporated into Clinical Development Plans and protocols as appropriate. Responsibilities: Leads and demonstrates ownership of the design and implementation of multiple clinical development programs (or one large, complex program) in support of the overall product development plan, based on strong medical and scientific principles, knowledge of compliance and regulatory requirements, AbbVie's customers, markets, business operations and emerging issues.
Clinical Dietitian - Cardiovascular And South Asian Translational Heart Initiative Clinic Stanford Health CareClinical Dietitian - Cardiovascular And South Asian Translational Heart Initiative ClinicPalo Alto, CA$48.26–$62.73 / hourSpecialty certification granted by the Commission on Dietetic Registration Board, Certified Nutrition Support Specialist (CNSC), Certified Clinical Transplant Dietitian (CCTD) or Certified Diabetes Care and Education Specialist (CDCES). The Clinical Dietitian II functions independently at the competent to proficient level of the SOP/SOPP to provide nutrition care to patients, including complex patient types.
Assistant/Associate/Full Professor - Applied Behavior Analysis California State UniversityAssistant/Associate/Full Professor - Applied Behavior AnalysisSan José, CA$88,000–$92,000 / yearD. in behavior analysis or related field, credentialing as a doctoral-level Board Certified Behavior Analyst (BCBA-D), capacity for leadership in a masters program in ABA, demonstrated scholarly productivity in behavior analysis, and awareness of and sensitivity to the educational goals of a multicultural population. Cutting-edge research, world-class scholarship, student-centered learning, diverse communities, and commitment to social justice, allow SJSU to provide life-changing opportunities and advance the public good locally and globally.
Principal Scientist, Cancer Pharmacology, Translational Research Revolution MedicinesPrincipal Scientist, Cancer Pharmacology, Translational ResearchRedwood City, California$190,000–$238,000 / yearAs a Principal Scientist in the Cancer Pharmacology team within the Translational Research group, in the Biomedical Discovery Research Department, you will: Provide scientific and strategic leadership for RAS(ON) inhibitor programs by translating mechanistic insights in RAS biology into impactful pharmacology strategies and translational study plans. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Principal Scientist, Cancer Pharmacology, Translational Research Revolution Medicines IncPrincipal Scientist, Cancer Pharmacology, Translational ResearchRedwood City, CA$190,000–$238,000 / yearThe Opportunity: As a Principal Scientist in the Cancer Pharmacology team within the Translational Research group, in the Biomedical Discovery Research Department, you will: Provide scientific and strategic leadership for RAS(ON) inhibitor programs by translating mechanistic insights in RAS biology into impactful pharmacology strategies and translational study plans. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Clinical Operations Revolution MedicinesAssociate Director, Clinical OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.
Associate Director, Clinical Operations Revolution Medicines IncAssociate Director, Clinical OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.